Table 3

 Standardised incidence ratios (SIRs) for malignant lymphomas associated with coeliac disease according to subtype (non-Hodgkin lymphoma (NHL) of B or T cell type or unspecified (UNS), Hodgkin lymphoma (HL)) and site of presentation (intestinal/non-intestinal)

No of cases
ObsExpSIR (95% CI)
95% CI, 95% confidence interval.
NHL558.36.6 (5.0–8.6)
HL11.01.0 (0.02–5.6)
NHL167.32.2 (1.3–3.6)
    B cell
    T cell370.851 (35–68)
    UNS20.38.1 (1.0–29)
    Intestinal301.224 (16–35)
    Non-intestinal257.13.6 (2.3–5.2)